IRBM Extends Peptide Therapeutics Collaboration with Merck & Co. Inc. Rahway NJ USA
Rome, Italy – IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD outside the USA and Canada, to continue their collaboration in the peptide therapeutics area.
